Lakefront Biotherapeutics NV (LKFT)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Lakefront Biotherapeutics NV’s filings yet. We add companies and filings all the time.
Track LKFT and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| Ameriprise Financial, Inc. | Aug 14, 2026 | $38.14M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Aug 14, 2026 | $18.02M |
| DME Capital Management, LP | Aug 14, 2026 | $14.47M |
| RENAISSANCE TECHNOLOGIES LLC | Aug 13, 2026 | $12.23M |
| BlackRock, Inc. | Aug 7, 2026 | $10.14M |
LKFT's filings are public. The insight is one click away.
Scrutar's AI reads every LKFT filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a LKFT filing.
Get an email when LKFT files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 16, 2026Source: SEC EDGAR.